Financials
Income statement
| Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.9B | 9.7B | 8.8B | 8.3B |
| Cost of revenue | 7.5B | 8.7B | 7.7B | 7.1B |
| Gross profit | 1.4B | 1.1B | 1.1B | 1.2B |
| Operating expense | ||||
| Research & development | 310M | 362M | 326M | 291M |
| Selling general and admin | 752M | 911M | 884M | 866M |
| Other operating expenses | 16M | 42M | — | -1M |
| Operating income | 336M | -190M | -40M | 69M |
| Non operating interest income | ||||
| Income | 63M | 68M | 54M | 47M |
| Expense | 72M | 65M | 106M | 101M |
| Other income expense | — | — | — | — |
| Pretax income | 462M | -69M | -108M | 298M |
| Tax provision | 211M | 184M | -6M | 189M |
| Net income | 252M | -254M | -102M | 108M |
| Basic EPS | 0.2 | -0.3 | -0.2 | — |
| Diluted EPS | 0.2 | -0.3 | -0.2 | — |
| Basic average shares | 864.3M | 862.8M | 862.8M | — |
| Diluted average shares | 864.3M | 862.8M | 862.8M | — |
| EBITDA | 904M | 429M | 358M | 756M |
| Net income from continuing op. | 252M | -254M | -102M | 108M |
| Minority interests | -53M | -39M | -40M | -40M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |